Published in Pain and Central Nervous System Week, June 23rd, 2003
A team led by Dr. Martin Garnett in the School of Pharmaceutical Sciences has been awarded a 206,000 pound grant from the Biotechnology and Biological Sciences Research Council to continue investigations on the preparation of nanoparticles for delivering drugs to brain tumors.
Anticancer drugs are problematic because they can cause significant problems in other nondiseased areas of the body too, leading to nasty side effects for the patient. For...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.